-
After 18 years of living with Alzheimer's disease, Marti Kaye spends most of her time in a wheelchair, expressionless. That changes the minute her son Adam Kaye starts playing his guitar.
-
In the 18-month trial, people in the early stages of Alzheimer's who received infusions of donanemab showed 35% less decline in thinking skills compared to those given a dummy drug, Lilly announced.
-
Programs assisting people with dementia — and their caregivers — improve quality of life and care. But millions of unpaid family and friend caregivers may not know where or how to find help.
-
A large study found that cutting down on alcohol is a good idea. People who quit drinking also had increased risk of dementia, but researchers cautioned about drawing conclusions from that.
-
Willis family announced Thursday that his previous diagnosis of aphasia has progressed to frontotemporal dementia. The disease can cause issues with speaking and writing.
-
Socially isolated older adults have a 27% higher chance of developing dementia, according to researchers from Johns Hopkins. The findings suggest that simple interventions could be meaningful.
-
For years, photographer Lori Grinker struggled to get along with her mother. When Lori moved into her mom's Aventura apartment to help with her mom's failing health (and continue chronicling her life), old wounds melted away.
-
An Alzheimer's drug that removes the substance amyloid from the brain has received a conditional approval from the FDA. A large study found the drug decreased the loss of thinking and memory by 27%.
-
Perkins in Winter Springs confirmed that it's the newest participant. Its back room will become a refuge for those diners every Tuesday afternoon.
-
In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.